Thank goodness, I was wondering what we were supposed to be afraid of next??

REPUBLIC, Wash. — A north Washington town may hold a gold deposit worth more than $3 billion.

Canadian mining company Calibre Mining Corp reported finding a high-value gold deposit on company-owned land called "The Golden Eagle". The town of Republic, Wash. sits only three miles away

https://www.krem.com/amp/article/news/local/washington/canadian-mining-company-finds-3-million-gold-deposit/293-4ac0280d-d117-449f-8107-97cfd00d17e1

REPUBLIC, Wash. — A north Washington town may hold a gold deposit worth more than $3 billion.

Canadian mining company Calibre Mining Corp reported finding a high-value gold deposit on company-owned land called "The Golden Eagle". The town of Republic, Wash. sits only three miles away.

https://www.krem.com/amp/article/news/local/washington/canadian-mining-company-finds-3-million-gold-deposit/293-4ac0280d-d117-449f-8107-97cfd00d17e1

News out.

WOW! Wish I were in.

Seems like you would give up sooner than later...your predictions are some of the most inaccurate I've seen. Don't quit your day job.

Try reading the latest financial report. OTC's numbers are way off.

Anyone notice the 1000 share trade this morning at 0.845? Probably nothing but interesting.

Agreed. 17 billion A/S & 7.3 billion O/S, Yikes!
Security Information
Trading Symbol: BAYP
Exact title and class of securities outstanding: Common
CUSIP: 073068 108
Par or Stated Value: .001
Total shares authorized: 17,000,000,000 as of: 9/30/2017
Total shares outstanding: 7,279,652,807 as of: 9/30/2017

Additional class of securities (if necessary):
Trading Symbol: BAYP
Exact title and class of securities outstanding: Preferred
CUSIP: 073068 108
Par or Stated Value: .01
Total shares authorized: 25,000,000 as of: 9/30/2017
Total shares outstanding: 24,000,000 as of:9/30/2017

Transfer Agent
Name: Pacific Stock Transfer Agent
Address 1: 6725 Via Austi Parkway
Address 2: Suite 300
Address 3: Las Vegas NV 89119
Phone: 800-785-7782

I would expect for things to heatup around here, based on that. But still nothing concrete, so who knows.

Innovation Pharmaceuticals Offers Perspectives on Brilacidin as a Potential Preventative Treatment for Oral Mucositis in Head and Neck Cancer Patients
 
BEVERLY, Mass., November 16, 2017 (GLOBE NEWSWIRE) – Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide additional perspectives on the planned continued development of Brilacidin-OM for the prevention and treatment of Oral Mucositis (OM) in Head and Neck Cancer (HNC) patients.
 
As previously announced, the Phase 2 randomized, placebo-controlled clinical trial of Brilacidin-OM (see NCT02324335), enrolling a total of 61 patients, recently was completed, with top-line analysis to be reported shortly.
 
After unblinding, should final study results compare favorably to those observed at interim, in which patients treated with Brilacidin-OM showed a markedly reduced rate of severe OM (WHO Grade ≥3) compared to those on placebo, the Company will initiate an aggressive development plan going forward, including: applying to the Food and Drug Administration (FDA) for Breakthrough Therapy Designation and possibly applying for a similar expedited path in Europe; enhancing oral rinse administration with patient-friendly formulation and packaging; and, dedicating internal resources to Phase 3 trial design planning and execution.
 
Formal collaboration with pharmaceutical companies that have expressed an interest in partnering Brilacidin-OM may well assist further with expediting the drug candidate’s development timetable. Some of these partnering conversations have matured to the point of potentially structuring mutually beneficial licensing agreements, pending the final Phase 2 study results.
 
“We very much look forward to taking what could be the final step in Brilacidin’s development for the prevention of OM—top-line results reporting followed by possible advancement into a pivotal Phase 3 trial,” said Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. “The OM market comprises a huge unmet medical need. To think we might one day help end the pain of so many patients suffering from OM, better enabling them to get the critical cancer care they need, would be an incredible accomplishment for Innovation Pharmaceuticals’ staff and a proud moment for our shareholders. Furthermore, securing partnerships with Pharma would represent a significant milestone for the Company, further anchoring the rapidly expanding Brilacidin Franchise.”
 
“What’s important to understand about Brilacidin-OM, at this stage of its development, is that it truly represents a potential breakthrough treatment in OM,” commented Arthur P. Bertolino, MD, PhD, MBA, President and Chief Medical Officer at Innovation Pharmaceuticals. “A majority of OM treatments currently being evaluated in clinical trials still target reduction in duration of OM symptoms, rather than going after OM prevention—what we’ve established as our primary efficacy outcome in the completed Phase 2 trial. We’ve set for ourselves a high bar, to be sure, but feel confident that if we deliver strong top-line results, Brilacidin-OM will stand apart from any future competition—a potential first-to-market and best-in-class OM treatment

Much appreciated.
I have checked out Twitter here and there, very randomly when someone puts up a link or something... just didn't realize that I SHOULD be checking it out. Until now.

Suppose I had better get with the ages. Thanks for your perspective.

Ahhhh....I don't tweet. Just seems odd to me. Or maybe I am a bit outdated, a sign of the times. Although, I certainly don't rely on tweeters in any of my other investments.

I am curious about the audit completion date. I was expecting an update on the last pr.
From the November 1st pr:

"Further details relating to the distribution business as well as the set launch date of Snakes & Lattes "Midtown" and audit completion date will be included in the company's next announcement"

The November 8th pr made zero mention of the audit completion date. What gives? Maybe I'm missing something?

Didn't last long

Much respect Mr. Tuna Pester and thanks for the mark, I'll mark you back. I don't post much but always lurking.

Take a look at the one year chart. You can easily spot the areas where short positions were opened. The window to cover is small though and the trend favors long positions.

Very small, and likely covered by now. I certainly wouldn't want to hold a short position here, not for any length of time. AMFE has been in a nice uptrend and I believe that trend will be tough to break. Imo.

Increase of 228% over previously reported short count. 126,185 shares reported short on current report. Previous report had roughly 55,350.

$73k worth. No chump change.

Look again

And by the way, if I were an insider, I wouldn't be buying too much right now...regardless of what I knew what was going to happen. It is illegal! In other words, I can't justify any argument that insider knowledge would drive pps too much.

Anyone who possess material knowledge about the company when that knowledge is not available to the public. You don't have to be directly involved in day to day activities to be considered an "insider".

While a buyback is always a possibility, I'm not confident. Us, as speculators, buy stock with hopes of appreciation. The company, however, enters the public marketplace for one reason and one reason only...as a vehicle to raise capital and create leverage. Having said that, I consider the options confronting management and either a raise of the A/S or a R/S makes most sense. Again just IMO.

I was wondering the same thing. I'm guessing a R/S of the commons is what will happen. Easiest way out of the predicament that they are in. Knock the common O/S down, while leaving the authorized alone then convert the perf's into commons when the time is right. IMO.

Don't forget about this..."The Houck Family Trust is the major shareholder of 66 Oilfield Services, LLC".

http://www.66oilfield.com/managment-team.html

Got me a stack of 16's...let her run!

More importantly, the float almost matches the O/S. Once those match, dilution is impossible until O/S is increased...which in this case would require an increase of the authorized. Great set-up for short term leverage. IMO.

Not to mention the repair of damaged equipment, replacement parts will be in high demand.

They can just as well up the authorized at will too.

And just to be clear for everyone reading, the 30mil is max authorized to be issued, not outstanding.

Theres 4.6mil preferred, not 46 million....talk about misinformation.

Looking good today.

Thanks and I will be adding as I see fit. Good luck to you as well.

I wouldn't believe everything you read and play the market like a game of chess....from the opponents point of view. Difference is the market has multiple opponents. Just my 2 cents.

Also, my broker said that it would be difficult and expensive to short this, loaners are tough to locate. Not that I planned on shorting, just like to know what the possibilities are. That being said, some broakers seem to be able to find loaners when others cannot, so who knows.

I think the company has a good thing going. The price may erode for a while, but that's why I only bought 2500 shares for now. The 85 cent per share is implied by the company, it was likely 10 cents, per the S1, and some sort of agreement on preferred shares. Thus my reservation on going too deep at this point. Folks should realize however that the shareholder support is critical right now if the plan is to come to fruition...hence my purchase today.

Time will tell. I'm not bashing here, just learned that being the devil's advocate can save you from losses. Kept me from jumping in at $2. Full disclosure, I opened a small long position this morning.

It did say "using the same or similar results..."
With all due respect, Those numbers are hugely important to those of us who like to make the best bet.